Journal
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume 405, Issue 26, Pages 8569-8577Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00216-013-7259-5
Keywords
Estradiol; Estrone; Mass spectrometry; Liquid chromatography; MRM summation
Funding
- senior Clinical Investigators of the Fund for Scientific Research Flanders (FWO-Vlaanderen)
- Clinical Research Fund of the University Hospitals Leuven, Belgium
- Fund for Scientific Research Flanders (FWO-Vlaanderen) [G085413N]
Ask authors/readers for more resources
The need for a routinely applicable assay to measure low estradiol levels in adult men, postmenopausal women, and young adolescents was recently discussed in an Endocrine Society position statement. Our aim was to develop a sensitive liquid chromatography-tandem mass spectrometry method for estradiol and estrone in human serum without the need for derivatization or extended extraction protocols. After protein precipitation of serum with a mixture of methanol/acetonitrile (85/15) (v/v) containing isotopic internal standards (17 beta-estradiol-16,16,17-d (3) and estrone-2,3,4-C-13), we quantified estradiol and estrone by two-dimensional liquid chromatography-tandem mass spectrometry with electrospray ionization in the negative mode monitoring 5 x 271.20 -> 145.00 (17 beta-estradiol) and 269.20 -> 145.00 (estrone). Sensitivity was increased by using fluoride and summation of 5 identical transitions for estradiol. Our method was analytically validated, compared against direct immunoassays using serum of 25 adult men, and clinically tested by measuring samples of 3 men at baseline and after chemical castration, 30 postmenopausal women and 15 patients receiving aromatase inhibitors. Total imprecision was below 20 % for the low quality controls. Limit of quantification was 1.3 ng/L (4.8 pmol/L) for estradiol and 1.2 ng/L (4.4 pmol/L) for estrone. Estradiol in Certified Reference Material BCR-576 was within specified uncertainty limits. No significant ion suppression or interference was observed. Our method showed modest correlation with direct immunoassay for estradiol (r (2) = 0.64) but no correlation for estrone (r (2) = 0.12). Patient sample results were within expected ranges. In conclusion, we developed a routinely applicable liquid chromatography-tandem mass spectrometry method for estradiol and estrone measurement which is sensitive enough for use in men, postmenopausal women, and young adolescents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available